Stoke TherapeuticsNASDAQ: STOK: Develops RNA-based therapies for severe genetic disorders.
10+ YOE5+ Mgmt10+ years CMC experience with drug-device combination products, 5+ years CMC leadership, bachelor's required (advanced degree preferred), deep CMC/regulatory knowledge, strong communication and cross-functional leadership.
Retro Biosciences: Developing therapies to extend healthy human lifespan.
7+ YOE7+ years hands-on regulatory CMC experience, experience leading CMC strategy for cell therapies, IND/CTA experience, ability to prepare CMC dossiers and lead health-authority interactions; life sciences degree preferred.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
10+ YOEBS in life sciences, 10+ years regulatory CMC or related pharma experience, experience with peptides and injectable dosage forms, ability to author CMC submissions and coordinate cross-functional inputs.
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
10+ YOE10+ years biopharma CMC regulatory experience for biologics/gene therapies; bachelor’s or master’s in life sciences; experience with post-approval CMC submissions, GMP and global regulatory frameworks; strong communication and cross-functional skills.
Cardinal HealthNYSE: CAH: Distributes pharmaceuticals and manufactures medical products for healthcare providers.
Supports CMC regulatory documentation and lifecycle management; familiarity with cGMP, ICH, CTD authoring preferred; bachelor's in related field or equivalent experience preferred; strong written/verbal communication and organizational skills.
Microsoft Word, Microsoft Excel, Microsoft PowerPoint, Adobe Acrobat
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
5+ YOEPhD or MS in pharmaceutical-related field; minimum 5 years CMC development experience; proven CMC dossier authoring; knowledge of regulatory and digital transformation in pharma; leadership and collaboration skills; Vault RIM, Word and Adobe proficiency.
WuXi BiologicsHong Kong Stock Exchange: 2269: Provides discovery, development, and manufacturing services for biologic drugs.
8+ YOEAdvanced degree (PhD/MS) with 8+ years relevant biologics CMC experience, regulatory/ICH knowledge, multi‑functional CMC expertise, project and people management, English and basic Mandarin communication.
First Tracks BiotherapeuticsNASDAQ: TRAX: Clinical-stage biotechnology developing antibody therapeutics for autoimmune diseases.
15+ YOE15+ MgmtBS required (PhD preferred); 15+ years senior CMC management experience in biologics; track record in global manufacturing, supply chain, CMO qualification, regulatory CMC submissions, and leadership of technical teams.
14+ YOEDirector/ Senior Director-level CMC leadership for lirentelimab; 14+ years in biotech with BLA/submission experience; cross-functional team leadership.
CMC, Regulatory, Quality, Bioanalytics, Process Development, Manufacturing
New York City or Salt Lake City or London or Montréal or Milton Park or Boston or San Francisco
$208k-$281k/yrRemoteFull Time
RecursionNASDAQ: RXRX: Developing medicines using an AI-native drug discovery platform.
8+ YOE8+ years CMC regulatory experience for small molecules, BA/BS or advanced degree, RAC preferred, deep knowledge of US, EU and ex-US CMC regulations, track record authoring INDs/NDAs, cross-functional collaboration.
Vera TherapeuticsNASDAQ: VERA: Develops treatments for serious immunological and autoimmune diseases.
6+ YOEBA/BS in a scientific field with minimum 6 years of regulatory affairs experience; strong US regulatory knowledge; CMC development in biologics preferred; proficient in regulatory information management systems (Veeva Vault RIM a plus).
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
10+ YOE3+ MgmtBachelor's in relevant field required; 10+ years biopharma experience with 3+ years enterprise leadership and 5+ years RA exposure; experience developing global regulatory CMC strategies and interfacing with agencies.
Vor BioNASDAQ: VOR: Developing targeted therapies for chronic autoimmune diseases.
8+ YOEDoctorate preferred; ≥8 years Regulatory CMC biologics experience with FDA sCDER interactions, global submissions, lifecycle management, and biologics/combination product development.
ModernaNasdaq: MRNA: Develops and manufactures messenger RNA medicines and vaccines.
15+ YOEDegree in life sciences or related field, 15 years relevant experience (or 10 years with PhD), deep stability science and CMC judgment, experience with stability strategy, regulatory submissions, leadership and cross-functional collaboration.